Welcia Holdings Co., Ltd. (WLCGF)
USD 16.41
(0.0%)
USD 16.41
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 326.87 Billion JPY | 16.45% |
| 2023 | 280.69 Billion JPY | 8.28% |
| 2022 | 259.23 Billion JPY | 9.67% |
| 2021 | 236.38 Billion JPY | 10.33% |
| 2020 | 214.25 Billion JPY | 10.79% |
| 2019 | 193.38 Billion JPY | 15.02% |
| 2018 | 168.13 Billion JPY | 13.54% |
| 2017 | 148.07 Billion JPY | 22.23% |
| 2016 | 121.14 Billion JPY | 19.97% |
| 2015 | 100.97 Billion JPY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 FY | 302.8 Billion JPY | 7.87% |
| 2024 Q1 | 79.51 Billion JPY | 0.77% |
| 2024 Q4 | 82.39 Billion JPY | 0.87% |
| 2024 Q3 | 81.67 Billion JPY | 2.46% |
| 2024 Q2 | 79.71 Billion JPY | 0.26% |
| 2023 Q2 | 74.92 Billion JPY | 6.84% |
| 2023 Q1 | 70.13 Billion JPY | -4.62% |
| 2023 FY | 280.69 Billion JPY | 8.28% |
| 2023 Q4 | 78.9 Billion JPY | 3.51% |
| 2023 Q3 | 76.22 Billion JPY | 1.73% |
| 2022 Q2 | 67.28 Billion JPY | 0.5% |
| 2022 Q1 | 66.94 Billion JPY | -4.78% |
| 2022 FY | 259.23 Billion JPY | 9.67% |
| 2022 Q4 | 73.52 Billion JPY | 7.7% |
| 2022 Q3 | 68.26 Billion JPY | 1.46% |
| 2021 Q1 | 58.73 Billion JPY | -6.43% |
| 2021 Q2 | 61.36 Billion JPY | 4.49% |
| 2021 Q4 | 70.3 Billion JPY | 10.0% |
| 2021 FY | 236.38 Billion JPY | 10.33% |
| 2021 Q3 | 63.91 Billion JPY | 4.15% |
| 2020 FY | 214.25 Billion JPY | 10.79% |
| 2020 Q2 | 56.33 Billion JPY | 2.64% |
| 2020 Q4 | 62.76 Billion JPY | 9.79% |
| 2020 Q1 | 54.88 Billion JPY | -2.6% |
| 2020 Q3 | 57.17 Billion JPY | 1.49% |
| 2019 Q4 | 56.34 Billion JPY | 8.98% |
| 2019 FY | 193.38 Billion JPY | 15.02% |
| 2019 Q3 | 51.7 Billion JPY | 1.85% |
| 2019 Q2 | 50.76 Billion JPY | 3.48% |
| 2019 Q1 | 49.05 Billion JPY | -3.31% |
| 2018 Q2 | 43.97 Billion JPY | 3.85% |
| 2018 FY | 168.13 Billion JPY | 13.54% |
| 2018 Q4 | 50.73 Billion JPY | 10.56% |
| 2018 Q1 | 42.34 Billion JPY | -1.38% |
| 2018 Q3 | 45.89 Billion JPY | 4.36% |
| 2017 Q2 | 39.14 Billion JPY | 1.96% |
| 2017 FY | 148.07 Billion JPY | 22.23% |
| 2017 Q4 | 42.93 Billion JPY | 7.5% |
| 2017 Q3 | 39.94 Billion JPY | 2.03% |
| 2017 Q1 | 38.39 Billion JPY | -2.75% |
| 2016 Q1 | 27.71 Billion JPY | 0.0% |
| 2016 FY | 121.14 Billion JPY | 19.97% |
| 2016 Q4 | 39.47 Billion JPY | 5.3% |
| 2016 Q3 | 37.48 Billion JPY | 31.43% |
| 2016 Q2 | 28.52 Billion JPY | 2.94% |
| 2015 FY | 100.97 Billion JPY | 0.0% |
| 2015 Q2 | 25.35 Billion JPY | 5.92% |
| 2015 Q3 | 25.31 Billion JPY | -0.13% |
| 2015 Q1 | 23.93 Billion JPY | 7.86% |
| 2014 Q4 | 22.19 Billion JPY | 0.38% |
| 2014 Q3 | 22.1 Billion JPY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | 3437.19 USD | -9510006620.606% |
| Allstar Health Brands, Inc. | 215.74 Thousand USD | -151509306.852% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 55.24 Million USD | -591621.0% |
| Café Serendipity Holdings, Inc. | 1.43 Million USD | -22758326.223% |
| Decision Diagnostics Corp. | - USD | -Infinity% |
| Health Advance Inc. | 47.57 Thousand USD | -687149363.948% |
| HealthWarehouse.com, Inc. | 13.79 Million USD | -2369329.899% |
| LIGAND PHARMACEUTICAL INC | 78.2 Million USD | -417874.554% |
| MedGen, Inc. | 16.59 USD | -1970325497187.523% |
| Omni Health, Inc. | 1.14 Million USD | -28497684.706% |
| Oxford Investments Holdings Inc. | 373.76 Thousand USD | -87456055.137% |
| Pineapple, Inc. | 452.94 Thousand USD | -72166462.166% |
| ScripsAmerica, Inc. | 31.4 Million USD | -1040763.933% |